Skip to main navigation
Our Science
Nucleos(t)ides
Pipeline & Programs
Hepatitis C
Bemnifosbuvir / Ruzasvir
About Hepatitis C
About Atea
About Us
Leadership
Careers
Contact
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
Annual Meeting
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Investor Relations
Event Details
Breadcrumb
Investors
7th Annual Evercore HealthCONx Conference
> Back to Events
Go Back
December 4, 2024
7th Annual Evercore HealthCONx Conference
Click Here for Webcast
Supporting Materials
Phase 2 Topline Results of Bemnifosbuvir + Ruzasvir in HCV Patients
672.6 KB
Investor FAQs
RSS Feeds
Email Alerts
Contact IR